Literature DB >> 29570848

Quality of Life in Huntington's Disease: Critique and Recommendations for Measures Assessing Patient Health-Related Quality of Life and Caregiver Quality of Life.

Tiago A Mestre1, Noelle E Carlozzi2, Aileen K Ho3, Jean-Marc Burgunder4, Francis Walker5, Aileen M Davis6, Monica Busse7, Lori Quinn8, Filipe B Rodrigues9,10,11, Cristina Sampaio12, Christopher G Goetz13, Esther Cubo14, Pablo Martinez-Martin15, Glenn T Stebbins11.   

Abstract

The compromise of quality of life in Huntington's disease is a major issue, both for individuals with the disease as well as for their caregivers. The International Parkinson and Movement Disorder Society commissioned a review of the use and clinimetric validation status of measures used in Huntington's disease to assess aspects related with quality of life and to make recommendations on their use following standardized criteria. We included both patient-centered measures (patient health-related quality-of-life measures) and caregiver-centered measures (caregiver quality-of-life measures). After conducting a systematic literature search, we included 12 measures of patient health-related quality of life and 2 measures of caregiver quality of life. Regarding patient-centered measures, the Medical Outcomes Study 36-Item Short-Form Health Survey is "recommended" as a generic assessment of health-related quality of life in patients with Huntington's disease. The 12-Item Short Form Health Survey, the Sickness Impact Profile, the 12-item World Health Organization Disability Assessment Schedule, and the Huntington's Disease Health-Related Quality of Life questionnaire are "suggested." No caregiver-centered quality-of-life measure obtained a "recommended" status. The Alzheimer's Carer's Quality of Life Inventory and the Huntington's Disease Quality of Life Battery for Carers are "suggested." Recognizing that the assessment of patient health-related quality of life can be challenging in Huntington's disease, as patients may lack insight and there is insufficient clinimetric testing of these scales, the committee concluded that further validation of currently available health-related quality-of-life measures should be undertaken, namely, those Huntington's disease-specific health-related quality-of-life measures that have recently been reported and used.
© 2018 International Parkinson and Movement Disorder Society. © 2018 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  Huntington's disease; caregiver-centered outcomes; patient-centered outcomes; quality of life; rating scales

Mesh:

Year:  2018        PMID: 29570848     DOI: 10.1002/mds.27317

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   9.698


  10 in total

1.  The risks of converting post-hoc findings into primary outcomes in subsequent trials.

Authors:  Filipe B Rodrigues; Joaquim J Ferreira
Journal:  Ann Transl Med       Date:  2019-12

2.  Brain, cognitive, and physical disability correlates of decreased quality of life in patients with Huntington's disease.

Authors:  Estefanía Junca; Mariana Pino; Hernando Santamaría-García; Sandra Baez
Journal:  Qual Life Res       Date:  2022-08-17       Impact factor: 3.440

3.  Disease Burden of Huntington's Disease (HD) on People Living with HD and Care Partners in Canada.

Authors:  Eileen Shaw; Michelle Mayer; Paul Ekwaru; Suzanne McMullen; Erin Graves; Jennifer W Wu; Nathalie Budd; Bridget Maturi; Tara Cowling; Tiago A Mestre
Journal:  J Huntingtons Dis       Date:  2022

Review 4.  Exercise in Huntington's Disease: Current State and Clinical Significance.

Authors:  Sandro Manuel Mueller; Jens A Petersen; Hans H Jung
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2019-02-04

5.  An International Validation of a Clinical Tool to Assess Carers' Quality of Life in Huntington's Disease.

Authors:  Aimee Aubeeluck; Edward J N Stupple; Malcolm B Schofield; Alis C Hughes; Lucienne van der Meer; Bernhard Landwehrmeyer; Aileen K Ho
Journal:  Front Psychol       Date:  2019-07-23

6.  Emotion recognition and inhibitory control in manifest and pre-manifest Huntington's disease: evidence from a new Stroop task.

Authors:  Thomas Hunefeldt; Sabrina Maffi; Simone Migliore; Ferdinando Squitieri; Marta Olivetti Belardinelli
Journal:  Neural Regen Res       Date:  2020-08       Impact factor: 5.135

7.  The use of wearable/portable digital sensors in Huntington's disease: A systematic review.

Authors:  Rosanna Tortelli; Filipe B Rodrigues; Edward J Wild
Journal:  Parkinsonism Relat Disord       Date:  2021-01-12       Impact factor: 4.891

8.  Social cognition and quality of life in Huntington's disease.

Authors:  Clare M Eddy; Hugh Rickards
Journal:  Front Psychiatry       Date:  2022-08-24       Impact factor: 5.435

9.  Responsiveness to change over time and test-retest reliability of the PROMIS and Neuro-QoL mental health measures in persons with Huntington disease (HD).

Authors:  Noelle E Carlozzi; Nicholas R Boileau; Matthew W Roché; Rebecca E Ready; Joel S Perlmutter; Kelvin L Chou; Stacey K Barton; Michael K McCormack; Julie C Stout; David Cella; Jennifer A Miner; Jane S Paulsen
Journal:  Qual Life Res       Date:  2020-08-19       Impact factor: 4.147

10.  Recent Advances and Future Perspectives in the Development of Therapeutic Approaches for Neurodegenerative Diseases.

Authors:  Melissa Bowerman
Journal:  Brain Sci       Date:  2020-09-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.